Vifor Pharma offers £23m to NHS to resolve CMA investigation
If accepted, Vifor Pharma's £23m offer will "claw back" money for the NHS and close the CMA's first-ever disparagement case.
Social Responsibility
UPFs fuelling ‘alarming rise of chronic diseases’ in india
Global conflicts prompt GPEI to delay polio eradication target
Advancing Pharmaceutical Security: The Role of SECURtracers in On-Dose Authentication
Social media algorithms are driving the GLP-1 drugs boom
As mpox spreads, ‘national governments have a moral responsibility to help’
